SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBaronsmead Vt Regulatory News (BVT)

Share Price Information for Baronsmead Vt (BVT)

Share Price is delayed by 15 minutes
Get Live Data
45.00    0.00 (0.00%)
Bid:
44.00
Ask:
46.00
Spread: 2.00 (4.545%)
Market Cap: £203.60m
BVT Live PriceLast checked at - London Stock Exchange

Intraday Baronsmead Vt Share Chart

Over-Allotment Facility and Offer Update

10 Feb 2026 07:00

RNS Number : 3037S
Baronsmead Venture Trust PLC
10 February 2026
 

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO, AUSTRALIA, CANADA, JAPAN, THE REPUBLIC OF SOUTH AFRICA, THE UNITED STATES OR ANY MEMBER STATE OF THE EEA (OTHER THAN ANY MEMBER STATE OF THE EEA WHERE THE COMPANY'S SECURITIES MAY BE LEGALLY MARKETED), OR ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO DISTRIBUTE THIS ANNOUNCEMENT. THE INFORMATION CONTAINED HEREIN DOES NOT CONSTITUTE OR FORM PART OF ANY OFFER TO ISSUE OR SELL, OR ANY SOLICITATION OF ANY OFFER TO SUBSCRIBE OR PURCHASE, ANY INVESTMENTS IN ANY JURISDICTION.

Baronsmead Venture Trust plc

LEI: 213800VQ1PQHOJXDDQ88

 

10 February 2026

Announcement of Intention to Utilise Over-Allotment Facility and Offer Update

The Board of Baronsmead Venture Trust plc (the "Company") announced on 13 October 2025 that the Company, together with Baronsmead Second Venture Trust plc, had published a prospectus (the "Prospectus") in relation to offers for subscription to raise up to £30 million in aggregate with the discretion to utilise over-allotment facilities to raise up to a further £20 million in aggregate (the "Offers" and each an "Offer"). Full details of the Offer are contained in the Prospectus dated 13 October 2025.

The Board is pleased to announce that valid applications have been received for over £12 million under the Company's Offer and therefore the initial amount of £15 million is likely to be fully subscribed for shortly. Accordingly, based on investor demand, the Board announce that they intend to utilise the full Over-allotment Facility of up to £10 million in respect of the Company's Offer.

The first allotment of shares in respect of valid applications accepted by the Company took place on 20 November 2025. The next scheduled allotment date is 19 February 2026. As stated in the Prospectus, the final allotment will only take place if the Offer is not fully subscribed by 2 April 2026 and the Board decides to extend the period of the Offer.

All capitalised terms used and not defined herein shall have the same meaning as in the Prospectus.

For further information please contact:

Baronsmead VCT Investor Relations

020 7382 0999

baronsmeadvcts@greshamhouse.com

 

 

Important Information

This Announcement is an advertisement for the purposes of the Prospectus Regulation Rules of the UK Financial Conduct Authority ("FCA") and is not a prospectus. This Announcement does not constitute or form part of, and should not be construed as, an offer for sale or subscription of, or solicitation of any offer to subscribe for or to acquire, any ordinary shares in Baronsmead Venture Trust plc or Baronsmead Second Venture Trust plc (together the "Companies") in any jurisdiction, including in or into Australia, Canada, Japan, the Republic of South Africa, the United States or any member state of the EEA (other than any member state of the EEA where the Companies' securities may be lawfully marketed). Investors should not subscribe for or purchase any ordinary shares referred to in this Announcement except on the basis of information in the prospectus (the "Prospectus") in its final form, published on 13 October 2025 by Baronsmead Venture Trust plc and Baronsmead Second Venture Trust plc, in connection with the Offer. A copy of the Prospectus is available for inspection, subject to certain access restrictions, from the Company's registered office, for viewing at the National Storage Mechanism at https://data.fca.org.uk/#/nsm/nationalstoragemechanism and on the Company's website (http://www.baronsmeadvcts.co.uk). Approval of the Prospectus by the FCA should not be understood as an endorsement of the securities that are the subject of the Prospectus. Potential investors are recommended to read the Prospectus before making an investment decision in order to fully understand the potential risks and rewards associated with a decision to invest in the Companies' securities.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUPUGWPUPQGQB
Date   Source Headline
16th Sep 20247:00 amRNSQuarterly Factsheet
5th Sep 20244:30 pmRNSNet Asset Value(s)
2nd Sep 202410:28 amRNSTotal Voting Rights
14th Aug 20245:43 pmRNSTransaction in Own Shares
7th Aug 202410:30 amRNSReplacement Net Asset Value(s)
6th Aug 20244:54 pmRNSNet Asset Value(s)
25th Jul 20245:30 pmRNSNet Asset Value(s)
1st Jul 202412:05 pmRNSTotal Voting Rights
26th Jun 20245:40 pmRNSTransaction in Own Shares
11th Jun 20247:05 amRNSDirectorate Change
11th Jun 20247:00 amRNSHalf-yearly Report
6th Jun 20241:30 pmRNSNet Asset Value(s)
3rd Jun 20242:41 pmRNSTotal Voting Rights
24th May 20245:52 pmRNSTransaction in Own Shares
7th May 20244:00 pmRNSNet Asset Value(s)
7th May 202411:51 amRNSCompliance with Market Abuse Regulation ("MAR")
1st May 202411:13 amRNSTotal Voting Rights
29th Apr 20243:30 pmRNSNet Asset Value(s)
3rd Apr 20247:00 amRNSTransaction in Own Shares
2nd Apr 20243:17 pmRNSTotal Voting Rights
28th Mar 202411:00 amRNSShare Allotment,Total Voting Rights,Close of Offer
19th Mar 20245:37 pmRNSClose of Offer to New Applications
18th Mar 20244:46 pmRNSDirector/PDMR Shareholding
15th Mar 20244:04 pmRNSTransaction in Own Shares
6th Mar 20243:00 pmRNSNet Asset Value(s)
6th Mar 20241:22 pmRNSResult of AGM
1st Mar 202410:20 amRNSTotal Voting Rights
15th Feb 20242:05 pmRNSDirector/PDMR Shareholding
15th Feb 20242:00 pmRNSAllotment of Shares and Total Voting Rights
7th Feb 202410:00 amRNSNet Asset Value(s)
2nd Feb 20248:00 amRNSIntention to Utilise Over-allotment Facility
1st Feb 20245:18 pmRNSTotal Voting Rights
1st Feb 20247:00 amRNSTransaction in Own Shares
30th Jan 202412:01 pmRNSDirector/PDMR Shareholding
30th Jan 202412:00 pmRNSDirector/PDMR Shareholding
26th Jan 20242:30 pmRNSAllotment of Shares and Total Voting Rights
24th Jan 20245:00 pmRNSNet Asset Value(s)
24th Jan 20244:00 pmRNSNet Asset Value(s)
22nd Jan 20243:00 pmRNSOffer Update Extension of Early Bird Discount Date
19th Jan 20242:35 pmRNSIssue of Supplementary Prospectus
5th Jan 202411:36 amRNSChange of allotment date - correction
4th Jan 20243:45 pmRNSChange of allotment date
2nd Jan 202411:00 amRNSTotal Voting Rights
22nd Dec 20237:00 amRNSAnnual Financial Report
12th Dec 20235:40 pmRNSTransaction in Own Shares
6th Dec 20231:30 pmRNSNet Asset Value(s)
24th Nov 20231:27 pmRNSPublication of a Prospectus/Offer for Subscription
22nd Nov 20237:00 amRNSCompliance with Market Abuse Regulation ("MAR")
14th Nov 202310:01 amRNSUpdate on Offer for Subscription
6th Nov 20234:01 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.